WO2002039972A1 - Insoluble organic uv filters and cosmetic use thereof - Google Patents
Insoluble organic uv filters and cosmetic use thereof Download PDFInfo
- Publication number
- WO2002039972A1 WO2002039972A1 PCT/FR2001/003482 FR0103482W WO0239972A1 WO 2002039972 A1 WO2002039972 A1 WO 2002039972A1 FR 0103482 W FR0103482 W FR 0103482W WO 0239972 A1 WO0239972 A1 WO 0239972A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bis
- phenylene
- cosmetic composition
- agents
- radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- ICXAPFWGVRTEKV-UHFFFAOYSA-N c(cc1)cc2c1[o]c(-c(cc1)ccc1-c1nc3ccccc3[o]1)n2 Chemical compound c(cc1)cc2c1[o]c(-c(cc1)ccc1-c1nc3ccccc3[o]1)n2 ICXAPFWGVRTEKV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Definitions
- the present invention relates to insoluble organic compounds filtering UN radiation, cosmetic compositions containing them as well as their use as agents screening UN radiation to protect materials sensitive to UN radiation, skin, hair or to control color. skin.
- the UN-A rays of wavelengths between 320 nm and 400 nm, which cause browning of the skin, are capable of inducing an alteration of the latter, in particular in the case of a sensitive skin or skin continuously exposed to solar radiation.
- the UN-A rays cause in particular a loss of elasticity of the skin and the appearance of wrinkles leading to premature aging. They promote the triggering of the erythematous reaction or amplify this reaction in certain subjects and can even be the cause of phototoxic or photoallergic reactions.
- UN-A radiation for aesthetic and cosmetic reasons such as the conservation of the natural elasticity of the skin for example, more and more people wish to control the effect of the UNA rays on their skin. It is therefore desirable to also filter UN-A radiation.
- sunscreens mainly in the form of soluble organic filters or insoluble mineral compounds. These filters must be able to absorb or block the harmful rays of the sun while remaining harmless to the user.
- a number of organic compounds with benzazole and / or benzofuranyl groups have already been proposed as sunscreens. Examples that may be mentioned include the 2-phenylbenzoxazoles, benzothiazoles and benzimidazoles described in the patents DE 676 103 and CH 350 763, the 2-arylbenzimidazoles described in patent US Pat. No. 5,501,850, the benzimidazolylbenzazoles ⁇ - substituted for patent US 5 961,960, the benzazole derivatives described in patent application EP A-0 669 323 or the benzofuranylbenzoxazoles of US patent 5,518,713, the bis-benzimidazole derivatives described in US patent 2,463,264 and in J. Am. Chem .
- insoluble organic UV filters of the oxalanilide, triazine, triazole, vinyl amide, cinnamamide and benzimidazole sulfonic type in the form of particles of average size between 0.01 and 2 ⁇ m.
- Some of these filters in particular the sulfonic benzimidazole derivatives, exhibit variations in solubility at high temperature which lead to significant recrystallization in the support. Such a phenomenon can occur result in a loss of effectiveness of the filters and a deterioration in the cosmetic properties of the compositions containing them.
- the Applicant following significant research in the field of photoprotection, has discovered new insoluble organic compounds containing one or more benzazole and / or benzofuran, be ⁇ zothiofen or indole groups capable of absorbing both in the UN-A and in UN-B, in the form of fine particles of average size between 10 nm and 5 ⁇ m, which allow effective protection of the skin, the lips or the hair as well as other photosensitive materials against the unfavorable effects UV radiation.
- benzazole includes both benzothiazoles, benzoxazoles and benzimidazoles.
- insoluble compound is meant, within the meaning of the present invention, a compound having a solubility in water of less than 0.1% by weight and a solubility of less than 1% by weight in most organic solvents such as paraffin, fatty alcohol benzoates and fatty acid triglycerides, for example Miglyol ® 812 sold by the company
- insoluble organic compounds make it possible to overcome the drawbacks of the soluble organic filters and the insoluble mineral filters of the prior art.
- These materials are more effective sun filters than the mineral filters of the prior art, since they combine two filtering mechanisms, namely the absorption of UV radiation by organic chromophores and the dispersion-reflection of light by particle surfaces. They are therefore entirely suitable for the preparation of cosmetic compositions intended for the protection of the skin and the hair against solar radiation.
- the insoluble organic compounds according to the invention have good chemical and photochemical stability.
- the present invention therefore relates to insoluble organic compounds filtering the UV radiation corresponding to one of the formulas (I), (II) and (III) below and which are in the form of particles having an average size comprised between 10 nm and 5 ⁇ m.
- the subject of the invention is also cosmetic compositions containing at least one insoluble organic compound of formula (I), (II) or (III), having an average size of between 10 nm and 5 ⁇ m.
- a subject of the invention is also the use of these insoluble compounds as agents for screening out UV-A and UV-B radiation, for example for the protection of materials sensitive to UV radiation, in particular to solar radiation, for controlling the color of the skin or for the preparation of drugs intended to prevent the harmful effects of UV-A and UV-B radiation.
- the insoluble organic compounds filtering UV radiation having an average size of between 10 nm and 5 ⁇ m are chosen from those corresponding to one of the following formulas (I), (II) and (III):
- each of the symbols Y independently represents an oxygen or sulfur atom or a group NR 2
- each of the symbols Z independently represents a nitrogen atom or a group CH
- each of the symbols Ri independently represents an OH group, an atom of halogen, a C ⁇ .g alkyl group, linear or branched, optionally containing a silicon atom, or a -s alkoxy group, linear or branched
- each of the numbers m is independently 0, 1 or 2
- n represents a whole number between 1 and 4 inclusive
- p is equal to 0 or 1
- each of the numbers q is independently equal to 0 or 1
- each of the symbols R 2 independently represents a hydrogen atom, a benzyl or C ⁇ alkyl group. 8 , linear or branched, optionally containing a silicon atom,
- A represents a radical of valence n chosen from those of formulas
- each of the symbols R 3 independently represents a halogen atom or a C or alkoxy, linear or branched, or hydroxy group
- the average size of the insoluble particles of the organic compounds described above is between 10 nm and 5 ⁇ m.
- the particles preferably have an average size of between 10 nm and 2 ⁇ m, and more preferably between 20 nm and 2 ⁇ m.
- the average particle size can be determined by any conventional method such as optical methods (quasi-elastic diffusion or laser diffusion), methods by centrifugation or methods of microscopic visualization and image analysis.
- the insoluble organic filters according to the invention can be brought in the particulate form having the desired average size by any suitable means, such as dry grinding or in solvent medium, sieving, atomization, micronization or spraying.
- the insoluble organic filters according to the invention can in particular be obtained by a process for grinding coarse particles into presence of one or more suitable surfactants making it possible to improve the dispersion of the particles thus obtained in cosmetic formulations.
- the grinding apparatus used according to these documents can be a jet, ball, vibration or hammer mill and preferably a high agitation mill or an impact mill and more particularly a rotary ball mill, a vibrating crusher, a tube crusher or a rod crusher.
- the insoluble organic compounds filtering UV can be used in cosmetic compositions, in particular compositions protecting the human epidermis or the hair, anti-sun compositions or make-up products.
- These cosmetic compositions generally contain from 0.1 to 15% by weight, preferably from 0.2 to 10% by weight, relative to the total weight of the cosmetic composition, of insoluble organic compounds filtering UV radiation.
- compositions of the present invention may also contain one or more additional organic sun filters, active in the UV-A and / or UV-B field, different from the insoluble filters described above.
- sunscreens can in particular be chosen from cinnamic derivatives, dibenzoylmethane derivatives, salicylic derivatives, benzylidenecamphor derivatives, triazine derivatives such as those described in patents or patent applications US 4367 390, EP 0 863 145, EP 0 517 104, EP 0 570 838, EP 0 796 851, EP 0 775 698, EP 0 878 469, EP 0 933 376 and EP 0 893 119, benzophenone derivatives, ⁇ , ⁇ '-diphenylacrylate derivatives , phenylbenzimidazole derivatives, anthranilic derivatives, imidazoline derivatives, methylene-bis- derivatives (hydroxyphenylbenzotriazole)
- UV-A and / or UN-B there may be mentioned as examples of such additional sunscreens active in UV-A and / or UN-B, the following compounds designated by their name I ⁇ CI, as well as their mixtures:
- UVINUL MS-40 sold under the trade name UVINUL MS-40 by BASF
- UVINUL DS-49 Benzophenone-9 sold under the trade name UVINUL DS-49 by BASF,
- phenylbenzotriazole derivatives - Drometrizole Trisiloxane sold under the trade name SILATRIZOLE by RHODIA CHIMIE,
- the more particularly preferred organic UV filters are chosen from the following compounds:
- the cosmetic compositions according to the invention may also contain agents for artificial tanning and / or browning of the skin (self-tanning agents) such as dihydroxy acetone (DH A).
- agents for artificial tanning and / or browning of the skin such as dihydroxy acetone (DH A).
- the cosmetic compositions according to the invention may also contain one or more mineral pigments and in particular nanopigments of metal oxides, coated or not, such as for example titanium oxide nanopigments in amorphous or crystallized form (rutile and / or anatase), iron oxide, zinc oxide, zirconium oxide or cerium oxide. These nanopigments have an average particle size of between 5 nm and
- nanopigments can be coated with known coating agents such as, for example, alumina and / or aluminum stearate. Such coated or uncoated nanopigments are described, for example, in patent applications EP-A-0 518 772 and EP-A-0 518 773.
- the cosmetic compositions may also contain usual adjuvants of formulation such as fatty substances, physiologically acceptable organic solvents, silicones, surfactants, anionic, cationic, nonionic, amphoteric polymers or their mixtures, thickening agents, antioxidants, clouding agents, stabilizers, defoamers, fragrances, preservatives, fillers, sequestering agents, propellants, pH adjusting agents, dyes and mixtures thereof.
- adjuvants of formulation such as fatty substances, physiologically acceptable organic solvents, silicones, surfactants, anionic, cationic, nonionic, amphoteric polymers or their mixtures, thickening agents, antioxidants, clouding agents, stabilizers, defoamers, fragrances, preservatives, fillers, sequestering agents, propellants, pH adjusting agents, dyes and mixtures thereof.
- They can also contain one or more cosmetic active ingredients chosen, for example, from softening agents, hydroxy acids, vitamins, hydrating agents, emollient agents, anti-free radical agents, substance P antagonists, anti-inflammatory agents. and mixtures of these compounds.
- the fatty substances can be constituted by an oil or a wax or their mixtures, and they also include fatty acids, fatty alcohols and fatty acid esters.
- the oils can be chosen from animal, vegetable, mineral or synthetic oils and in particular from petrolatum, paraffin oil, silicone oils, volatile or not, isoparaffins, polyolefins, fluorinated and perfluorinated oils.
- the waxes can be chosen from animal, fossil, vegetable, mineral or synthetic waxes known per se.
- the thickeners may be chosen in particular from guar gums and celluloses, modified or not, such as hydroxypropylated guar gum, methylhydroxyethylcellulose, hydroxypropylmethylcellulose or also hydroxyethylcellulose.
- compositions of the invention can be prepared according to techniques well known to those skilled in the art, in particular those intended for the preparation of emulsions of the oil-in-water or water-in-oil type.
- This composition can be in particular in the form of an emulsion, simple or complex (O / W, W / O, HE / O or W / O / W) such as a cream, a milk, a gel or a gel- cream, powder or solid stick, and can optionally be packaged as an aerosol and come in the form of a foam or spray.
- the aqueous phase thereof may comprise a nonionic vesicular dispersion prepared according to known methods (Bangham, Standish and Watkins, J. Mol. Biol. 13, 238 (1965), FR 2 315 991 and FR 2 416 008).
- the cosmetic composition of the invention can be used as a composition for protecting the human epidermis or the hair against ultraviolet rays, as an anti-sun composition or as a make-up product.
- the cosmetic composition according to the invention may be in the form of a suspension or of dispersion in solvents or fatty substances, in the form of nonionic vesicular dispersion or alternatively in the form of an emulsion, preferably of the oil-in-water type, such as a cream or a milk, in the form of an ointment, gel, cream gel, solid stick, stick, powder, aerosol foam or spray.
- the cosmetic composition according to the invention when used for protecting the hair against UV rays, it can be in the form of a shampoo, lotion, gel, emulsion, nonionic vesicular dispersion and constitute, for example, a composition to rinse, apply before or after shampooing, before or after coloring or discoloration, before, during or after permanent or straightening, a styling or treating lotion or gel, a brushing lotion or gel. or styling, a composition of permanent or straightening, coloring or bleaching of the hair.
- the composition When the composition is used as a makeup product for the eyelashes, the eyebrows or the skin, such as an epidermis treatment cream, a foundation of lipstick, a lipstick stick, eyeshadow, blush, mascara or liner also called “eyeliner", it can be in solid or pasty, anhydrous or aqueous form, such as oil-in-water or water-in-oil emulsions, nonionic vesicular dispersions or suspensions.
- the aqueous phase generally represents from 50 to 95% by weight, preferably from 70 to 90% by weight. weight, relative to the entire formulation, the oily phase of 5 to 50% by weight, preferably 10 to 30% by weight, relative to the entire formulation, and the (co) emulsifier (s) from 0.5 to
- the insoluble filtering agents of the present invention can also be used to protect materials, such as organic or mineral glasses or plastics, sensitive to radiation.
- UV especially solar radiation.
- the particles are then applied to or incorporated into the material to be protected in an effective amount.
- the subject of the invention is also a non-therapeutic process for protecting the skin and / or the hair against ultraviolet radiation, in particular solar radiation, which consists in applying to the skin or the hair an effective amount of the cosmetic composition. defined above, or of a compound of formula (I), (II) or (III) as defined above.
- the invention finally relates to a non-therapeutic process for controlling the variation in skin color due to UV radiation, which consists in applying to the skin an effective amount of the cosmetic composition defined above, or of a compound of formula (I), (II) or (III) as defined above.
- a heterogeneous mixture is heated consisting of 50 g (0.3 mole) of terephthalic acid, 131 g (1.2 moles) of 2-aminophenol, 1.2 g of boric acid and 360 g of acid polyphosphoric, for 4 hours under a nitrogen atmosphere and stirring at a temperature between 190 and
- the average diameter of the number distribution for the sample thus obtained determined using a Mastersizer 2000 device from the company
- MALVERN is 0.450 ⁇ m.
- the particle size profile is shown in Figure 1 of the accompanying drawing.
- a heterogeneous mixture of 66.4 g (0.4 mole) of terephthalic acid, 199 g (1.84 mole) of ortho-phenylenediamine, 6 g of boric acid and 50 ml of N- is heated.
- methylpyrrolidone for a few minutes under a nitrogen atmosphere at a temperature of 70 - 80 ° C, then, with nitrogen bubbling, the mixture is heated to 190 - 200 ° C, and maintained for 5 hours at this temperature.
- the water formed distills and is collected by the distillation ramp.
- the mixture is allowed to cool to about 100 ° C and 135 ml of N-methylpyrrolidone is carefully added to it. Cool to 20 ° C, separate the solid obtained by filtration and wash with N-methylpyrrolidone, then with a mixture of N-methylpyrrolidone / ethanol
- the predispersion obtained by pumping is introduced into the bowl (capacity 150 ml) of a Dyno-Mill type ball mill marketed by the company WAB, filled up to 80% of its capacity with glass beads of 1 mm in diameter . Grinding is carried out in a closed circuit for 2 hours 30 minutes with circulation of water to avoid overheating of the preparation. The dispersion obtained is stabilized using xanthan gum. The grinding can also be carried out with circulation of the dispersion continuously during the entire grinding time.
- the particle size profile is shown in Figure 2 of the accompanying drawing.
- LANETTE ® 18 from HENKEL Stearyl alcohol
- the fatty phase and the aqueous phase are heated separately to 70 ° C., then the oily phase is introduced into the aqueous phase with stirring. Stirring is continued for approximately 15 minutes and allowed to cool with slow stirring until the composition returns to room temperature.
- the oil-in-water cream is prepared as described in Example A.
- the effectiveness of this composition is evaluated in vitro using a spectroradiometer of the SPF 290 type sold by the company Optometrics and according to the method of Diffey and Robson (BL Diffey et al, J. Soc Cosmet. Chem., 40 , 127 - 133 (1989)) on quartz plate coated with Transpore ® tape.
- the sun protection factor (SPF) is equal to 7.6 ⁇ 1.5.
- the oil-in-water cream is prepared as described in Example A.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cosmetics (AREA)
Abstract
Description
Filtres UV organiques insolubles et leur utilisation en cosmétique Insoluble organic UV filters and their use in cosmetics
La présente invention concerne des composés organiques insolubles filtrant le rayonnement UN, des compositions cosmétiques les contenant ainsi que leur utilisation à titre d'agents filtrants le rayonnement UN pour protéger des matériaux sensibles au rayonnement UN, la peau, les cheveux ou pour contrôler la couleur de la peau.The present invention relates to insoluble organic compounds filtering UN radiation, cosmetic compositions containing them as well as their use as agents screening UN radiation to protect materials sensitive to UN radiation, skin, hair or to control color. skin.
On sait que les radiations lumineuses de longueurs d'onde comprises entre 280 nm et 400 nm permettent le brunissement de l'épidémie humain et que les rayons de longueurs d'onde comprises entre 280 et 320 nm, connus sous la dénomination d'UN-B, provoquent des érythèmes et des brûlures cutanées qui peuvent nuire au développement du bronzage naturel. Pour ces raisons, ainsi que pour des raisons esthétiques, il existe une demande constante de moyens de contrôle de ce bronzage naturel en vue de contrôler ainsi la couleur de la peau. Il convient donc de filtrer ce rayonnement UN-B.We know that light radiation with wavelengths between 280 nm and 400 nm allows the browning of the human epidemic and that rays with wavelengths between 280 and 320 nm, known under the name of UN- B, cause erythema and skin burns which can affect the development of natural tanning. For these reasons, as well as for aesthetic reasons, there is a constant demand for means of controlling this natural tan in order to thereby control the color of the skin. It is therefore advisable to filter this radiation UN-B.
On sait également que les rayons UN-A, de longueurs d'onde comprises entre 320 nm et 400 nm, qui provoquent le brunissement de la peau, sont susceptibles d'induire une altération de celle-ci, notamment dans le cas d'une peau sensible ou d'une peau continuellement exposée au rayonnement solaire. Les rayons UN-A provoquent en particulier une perte d'élasticité de la peau et l'apparition de rides conduisant à un vieillissement prématuré. Ils favorisent le déclenchement de la réaction érythémateuse ou amplifient cette réaction chez certains sujets et peuvent même être à l'origine de réactions phototoxiques ou photo-allergiques. Ainsi, pour des raisons esthétiques et cosmétiques telles que la conservation de l'élasticité naturelle de la peau par exemple, de plus en plus de personnes désirent contrôler l'effet des rayons UNA sur leur peau. Il est donc souhaitable de filtrer aussi le rayonnement UN- A.It is also known that the UN-A rays, of wavelengths between 320 nm and 400 nm, which cause browning of the skin, are capable of inducing an alteration of the latter, in particular in the case of a sensitive skin or skin continuously exposed to solar radiation. The UN-A rays cause in particular a loss of elasticity of the skin and the appearance of wrinkles leading to premature aging. They promote the triggering of the erythematous reaction or amplify this reaction in certain subjects and can even be the cause of phototoxic or photoallergic reactions. Thus, for aesthetic and cosmetic reasons such as the conservation of the natural elasticity of the skin for example, more and more people wish to control the effect of the UNA rays on their skin. It is therefore desirable to also filter UN-A radiation.
Un grand nombre de composés ont déjà été proposés comme filtres solaires, essentiellement sous la forme de filtres organiques solubles ou de composés minéraux insolubles. Ces filtres doivent pouvoir absorber ou bloquer les rayons nocifs du soleil tout en restant inoffensifs pour l'utilisateur.A large number of compounds have already been proposed as sunscreens, mainly in the form of soluble organic filters or insoluble mineral compounds. These filters must be able to absorb or block the harmful rays of the sun while remaining harmless to the user.
A cet égard, et afin de limiter les éventuels risques d'allergie cutanée associés à l'utilisation de filtres organiques solubles, on utilise depuis un certain temps de plus en plus de composés minéraux insolubles tels que l'oxyde de zinc ou encore l'oxyde de titane. Cependant, ces composés minéraux peuvent présenter l'inconvénient d'être sensibles au rayonnement solaire. Par ailleurs, à quantités équivalentes, ces composés minéraux sont moins efficaces dans la protection UN que les filtres organiques.In this regard, and in order to limit the possible risks of skin allergy associated with the use of soluble organic filters, more and more insoluble mineral compounds have been used for some time such as zinc oxide or titanium oxide. However, these mineral compounds can have the disadvantage of being sensitive to solar radiation. Furthermore, in equivalent quantities, these mineral compounds are less effective in UN protection than organic filters.
Un certain nombre de composés organiques à groupes benzazoles et/ou benzofuranyle ont déjà été proposés comme filtres solaires. On peut citer à titre d'exemples les 2-phénylbenzoxazoles, benzothiazoles et benzimidazoles décrits dans les brevets DE 676 103 et CH 350 763, les 2-arylbenzimidazoles décrits dans le brevet US 5 501 850, les benzimidazolylbenzazoles Ν- substitués du brevet US 5 961 960, les dérivés de benzazoles décrits dans la demande de brevet EP A-0 669 323 ou les benzofuranylbenzoxazoles du brevet US 5 518 713, les dérivés de bis-benzimidazoles décrits dans le brevet US 2 463 264 et dans J. Am. Chem. Soc, 79, 5706 - 5708, 1957, les dérivés de bis-benzoxazoles décrits dans J. Am. Chem. Soc, 82, 609 - 611, 1960, les composés siliciés de benzazoles décrits dans la demande de brevet EP-A-0 921 126 ou les dérivés siliciés de benzimidazoles de la demande de brevet EP-A-0 712 855. Aucun de ces documents ne mentionne cependant l'utilisation de ces filtres sous forme de particules insolubles de très petite taille, c'est-à-dire une taille de l'ordre du micron ou inférieure au micron.A number of organic compounds with benzazole and / or benzofuranyl groups have already been proposed as sunscreens. Examples that may be mentioned include the 2-phenylbenzoxazoles, benzothiazoles and benzimidazoles described in the patents DE 676 103 and CH 350 763, the 2-arylbenzimidazoles described in patent US Pat. No. 5,501,850, the benzimidazolylbenzazoles Ν- substituted for patent US 5 961,960, the benzazole derivatives described in patent application EP A-0 669 323 or the benzofuranylbenzoxazoles of US patent 5,518,713, the bis-benzimidazole derivatives described in US patent 2,463,264 and in J. Am. Chem . Soc, 79, 5706-5708, 1957, the bis-benzoxazole derivatives described in J. Am. Chem. Soc, 82, 609 - 611, 1960, the silicon benzazole compounds described in patent application EP-A-0 921 126 or the silicon benzimidazole derivatives of patent application EP-A-0 712 855. None of these However, documents do not mention the use of these filters in the form of very small insoluble particles, that is to say a size of the order of a micron or less than a micron.
On connaît également, par les documents WO 95/22959 et WO 97/03643, des filtres UV organiques insolubles du type oxalanilide, triazine, triazole, amide vinylique, cinnamamide et benzimidazole sulfonique sous forme de particules de taille moyenne comprise entre 0,01 et 2 μm.Also known from documents WO 95/22959 and WO 97/03643 are insoluble organic UV filters of the oxalanilide, triazine, triazole, vinyl amide, cinnamamide and benzimidazole sulfonic type in the form of particles of average size between 0.01 and 2 μm.
Certains de ces filtres, en particulier les dérivés de benzimidazole sulfonique, présentent des variations de solubilité à température élevée qui conduisent à une recristallisation importante dans le support. Un tel phénomène peut se traduire par une perte d'efficacité des filtres et une détérioration des propriétés cosmétiques des compositions les contenant.Some of these filters, in particular the sulfonic benzimidazole derivatives, exhibit variations in solubility at high temperature which lead to significant recrystallization in the support. Such a phenomenon can occur result in a loss of effectiveness of the filters and a deterioration in the cosmetic properties of the compositions containing them.
La demanderesse, suite à d'importantes recherches dans le domaine de la photoprotection, a découvert de nouveaux composés organiques insolubles contenant un ou plusieurs groupements benzazole et/ou benzofuranne, beήzothiofène ou indole capables d'absorber à la fois dans l'UN-A et dans l'UN-B, se trouvant sous forme de fines particules de taille moyenne comprise entre 10 nm et 5 μm, qui permettent de protéger efficacement la peau, les lèvres ou les cheveux ainsi que d'autres matériaux photosensibles contre les effets défavorables du rayonnement UV.The Applicant, following significant research in the field of photoprotection, has discovered new insoluble organic compounds containing one or more benzazole and / or benzofuran, beήzothiofen or indole groups capable of absorbing both in the UN-A and in UN-B, in the form of fine particles of average size between 10 nm and 5 μm, which allow effective protection of the skin, the lips or the hair as well as other photosensitive materials against the unfavorable effects UV radiation.
Au sens où on l'utilise dans la présente invention, le terme benzazole englobe à la fois les benzothiazoles, benzoxazoles et benzimidazoles.As used in the present invention, the term benzazole includes both benzothiazoles, benzoxazoles and benzimidazoles.
On entend par composé insoluble, au sens de là présente invention, un composé ayant une solubilité dans l'eau inférieure à 0,1 % en poids et une solubilité inférieure à 1 % en poids dans la plupart des solvants organiques comme l'huile de paraffine, les benzoates d'alcools gras et les triglycérides d'acides gras, par exemple le Miglyol® 812 commercialisé par la sociétéBy insoluble compound is meant, within the meaning of the present invention, a compound having a solubility in water of less than 0.1% by weight and a solubility of less than 1% by weight in most organic solvents such as paraffin, fatty alcohol benzoates and fatty acid triglycerides, for example Miglyol ® 812 sold by the company
DYΝAMIT NOBEL. Cette solubilité, définie à 70 °C comme la quantité de produit en solution dans le solvant à l'équilibre avec un excès de solide en suspension, peut facilement être évaluée au laboratoire.DYΝAMIT NOBEL. This solubility, defined at 70 ° C as the amount of product in solution in the solvent at equilibrium with an excess of solid in suspension, can easily be evaluated in the laboratory.
Ces composés organiques insolubles permettent de surmonter les inconvénients des filtres organiques solubles et des filtres minéraux insolubles de l'art antérieur. Ces matériaux sont des filtres solaires plus efficaces que les filtres minéraux de l'état de la technique, puisqu'ils cumulent deux mécanismes de filtrage, à savoir l'absorption du rayonnement UV par les chromophores organiques et la dispersion-réflexion de la lumière par les surfaces des particules. Ils sont donc tout à fait appropriés pour la préparation de compositions cosmétiques destinées à la protection de la peau et des cheveux contre le rayonnement solaire. De plus, outre leurs propriétés filtrantes et dispersantes, les composés organiques insolubles selon l'invention présentent une bonne stabilité chimique et photochimique. La présente invention a par conséquent pour objet des composés organiques insolubles filtrant le rayonnement UV correspondant à l'une des formules (I), (II) et (III) ci-après et qui se présentent sous forme de particules ayant une taille moyenne comprise entre 10 nm et 5 μm.These insoluble organic compounds make it possible to overcome the drawbacks of the soluble organic filters and the insoluble mineral filters of the prior art. These materials are more effective sun filters than the mineral filters of the prior art, since they combine two filtering mechanisms, namely the absorption of UV radiation by organic chromophores and the dispersion-reflection of light by particle surfaces. They are therefore entirely suitable for the preparation of cosmetic compositions intended for the protection of the skin and the hair against solar radiation. In addition, in addition to their filtering and dispersing properties, the insoluble organic compounds according to the invention have good chemical and photochemical stability. The present invention therefore relates to insoluble organic compounds filtering the UV radiation corresponding to one of the formulas (I), (II) and (III) below and which are in the form of particles having an average size comprised between 10 nm and 5 μm.
L'invention a également pour objet des compositions cosmétiques contenant au moins un composé organique insoluble de formule (I), (II) ou (III), ayant une taille moyenne comprise entre 10 nm et 5 μm.The subject of the invention is also cosmetic compositions containing at least one insoluble organic compound of formula (I), (II) or (III), having an average size of between 10 nm and 5 μm.
L'invention a également pour objet l'utilisation de ces composés insolubles comme agents filtrant le rayonnement UV-A et UV-B, par exemple pour la protection de matériaux sensibles au rayonnement UV, en particulier au rayonnement solaire, pour contrôler la couleur de la peau ou pour la préparation de médicaments destinés à prévenir les effets néfastes du rayonnement UV-A et UV-B.A subject of the invention is also the use of these insoluble compounds as agents for screening out UV-A and UV-B radiation, for example for the protection of materials sensitive to UV radiation, in particular to solar radiation, for controlling the color of the skin or for the preparation of drugs intended to prevent the harmful effects of UV-A and UV-B radiation.
Les composés organiques insolubles filtrant le rayonnement UV ayant une taille moyenne comprise entre 10 nm et 5 μm sont choisis parmi ceux correspondant à l'une des formules (I), (II) et (III) suivantes :The insoluble organic compounds filtering UV radiation having an average size of between 10 nm and 5 μm are chosen from those corresponding to one of the following formulas (I), (II) and (III):
dans lesquelles chacun des symboles Y représente indépendamment un atome d'oxygène ou de soufre ou un groupe NR2, chacun des symboles Z représente indépendamment un atome d'azote ou un groupe CH, chacun des symboles Ri représente indépendamment un groupe OH, un atome d'halogène, un groupe alkyle en Cι.g, linéaire ou ramifié, contenant éventuellement un atome de silicium, ou un groupe alcoxy en -s, linéaire ou ramifié, chacun des nombres m vaut indépendamment 0, 1 ou 2, n représente un nombre entier compris entre 1 et 4 inclus, p est égal à 0 ou 1, chacun des nombres q est égal indépendamment à 0 ou 1, chacun des symboles R2 représente indépendamment un atome d'hydrogène, un groupe benzyle ou alkyle en Cι.8, linéaire ou ramifié, contenant éventuellement un atome de silicium, in which each of the symbols Y independently represents an oxygen or sulfur atom or a group NR 2 , each of the symbols Z independently represents a nitrogen atom or a group CH, each of the symbols Ri independently represents an OH group, an atom of halogen, a Cι.g alkyl group, linear or branched, optionally containing a silicon atom, or a -s alkoxy group, linear or branched, each of the numbers m is independently 0, 1 or 2, n represents a whole number between 1 and 4 inclusive, p is equal to 0 or 1, each of the numbers q is independently equal to 0 or 1, each of the symbols R 2 independently represents a hydrogen atom, a benzyl or Cι alkyl group. 8 , linear or branched, optionally containing a silicon atom,
A représente un radical de valence n choisi parmi ceux de formules A represents a radical of valence n chosen from those of formulas
(b) (c) ( ) (e)(b) (c) () (e)
(0 (j) (k) (D ( 0 (j) (k) (D
(m) (n) (o)(m) (n) (o)
dans lesquelles chacun des symboles R3 représente indépendamment un atome d'halogène ou un groupe alkyle ou alcoxy en C , linéaire ou ramifié, ou hydroxy,in which each of the symbols R 3 independently represents a halogen atom or a C or alkoxy, linear or branched, or hydroxy group,
R représente un atome d'hydrogène ou un groupe alkyle en Cμ , linéaire ou ramifié, c = 0 - 4, d = 0 - 3, e = 0 ou 1, et f = 0 - 2.R represents a hydrogen atom or a linear or branched Cμ alkyl group, c = 0 - 4, d = 0 - 3, e = 0 or 1, and f = 0 - 2.
A titre d'exemples de composés préférés de formule (I) de la famille des 2-arylbenzazoles, on peut mentionner le 2-benzoxazol-2-yl-4- méthylphénol, le 2-(lH-benzimidazol-2-yl)-4-méthoxyphénol ou le 2- benzothiazol-2-ylphénol, ces composés pouvant être préparés par exemple selon les procédés décrits dans le brevet CH 350 763. A titre d'exemples de composés préférés de formule (I) de la famille des benzimidazolylbenzazoles, on citera le 2,2'-bis-benzimidazole, le 5,5',6,6'- tétraméthyl-2,2'-bis-benzimidazole, le 5,5'-diméthyl-2,2'-bis-benzimidazoIe, le 6-méthoxy-2,2'-bis-benzimidazole, le 2-(lH-benzimidazol-2-yl)~ benzothiazole, le 2-(lH-benzimidazol-2-yl)-benzoxazole et le N,N'-diméthyl~As examples of preferred compounds of formula (I) from the family of 2-arylbenzazoles, mention may be made of 2-benzoxazol-2-yl-4-methylphenol, 2- (1H-benzimidazol-2-yl) - 4-methoxyphenol or 2-benzothiazol-2-ylphenol, these compounds being able to be prepared for example according to the methods described in patent CH 350 763. As examples of preferred compounds of formula (I) of the family of benzimidazolylbenzazoles, mention will be made of 2,2'-bis-benzimidazole, 5.5 ', 6,6'- tetramethyl-2,2'-bis -benzimidazole, 5,5'-dimethyl-2,2'-bis-benzimidazoIe, 6-methoxy-2,2'-bis-benzimidazole, 2- (1H-benzimidazol-2-yl) ~ benzothiazole, 2- (1H-benzimidazol-2-yl) -benzoxazole and N, N'-dimethyl ~
2,2'-bis-benzimidazole, ces composés pouvant être préparés selon les modes opératoires décrits dans les brevets US 5 961 960 et US 2 463 264.2,2'-bis-benzimidazole, these compounds can be prepared according to the procedures described in US Patents 5,961,960 and US 2,463,264.
A titre d'exemples de composés préférés de formule (I) de la famille des phénylène-benzazoles, on citera le l,4-phénylène-bis-(2-benzoxazolyle), le l,4-phénylène-bis-(2-benzimidazolyle), le l,3-phénylène-bis-(2- benzoxazolyle), le l,2-phénylène-bis-(2-benzoxazolyle), le 1,2-phénylène-bis- (benzimidazolyle), le 1 ,4-phénylène-bis-(N-2-éthylhexyl-2-benzimidazolyle) et le l,4-phénylène-bis-(N-triméthylsilylméthyl-2-benzimidazolyle), ces composés pouvant être préparés selon les modes opératoires décrits dans le brevet US 2 463 264 et dans les publications J. Am.Chem. Soc, 82, 609As examples of preferred compounds of formula (I) from the phenylene-benzazole family, mention will be made of 1,4-phenylene-bis- (2-benzoxazolyl), 1,4-phenylene-bis- (2- benzimidazolyle), 1,3-phenylene-bis- (2-benzoxazolyle), 1,2-phenylene-bis- (2-benzoxazolyle), 1,2-phenylene-bis- (benzimidazolyl), 1,4 -phenylene-bis- (N-2-ethylhexyl-2-benzimidazolyl) and 1,4-phenylene-bis- (N-trimethylsilylmethyl-2-benzimidazolyl), these compounds can be prepared according to the procedures described in the US patent 2,463,264 and in the publications J. Am.Chem. Soc, 82, 609
(1960) et J. Am. Chem. Soc, 79, 5706 - 5708 (1957).(1960) and J. Am. Chem. Soc, 79, 5706-5708 (1957).
A titre d'exemples de composés préférés de formule (I) de la famille des benzofuranyl-benzoxazoles, on citera le 2-(2-benzofuranyl)-benzoxazole, le 2-(benzofuranyl)-5-méthylbenzoxazole et le 2-(3-méthyl-2-benzofuranyle)- benzoxazole, ces composés pouvant être préparés selon les modes opératoires décrits dans le brevet US 5 518 713.As examples of preferred compounds of formula (I) of the family of benzofuranyl-benzoxazoles, mention may be made of 2- (2-benzofuranyl) -benzoxazole, 2- (benzofuranyl) -5-methylbenzoxazole and 2- (3 -methyl-2-benzofuranyl) - benzoxazole, these compounds can be prepared according to the procedures described in US Pat. No. 5,518,713.
Comme composés préférés de formule (II), on peut citer par exemple le 2,6-diphényl-l,7-dihydro-benzo[l,2-d;4,5-d']-di-imidazole correspondant à la formuleAs preferred compounds of formula (II), there may be mentioned, for example, 2,6-diphenyl-1,7-dihydro-benzo [1,2-d; 4,5-d '] - di-imidazole corresponding to the formula
ou le 2,6-distyryl-l,7-dihydro-benzo[l,2-d ; 4,5-d']-di-imidazole ou encore le 2,6-di(p-tert-butylstyryl)-l,7-dihydrobenzo[l,2-d ; 4,5-d']-di-imidazole, qui peuvent être préparés selon la demande EP 0 669 323. Comme composé préféré de formule (III), on peut citer le 5,5'-bis- [(phényl-2)-benzimidazole] de formule :or 2,6-distyryl-1,7-dihydro-benzo [1,2-d; 4,5-d '] - di-imidazole or 2,6-di (p-tert-butylstyryl) -1,7-dihydrobenzo [1,2-d; 4,5-d '] - di-imidazole, which can be prepared according to application EP 0 669 323. As preferred compound of formula (III), mention may be made of 5,5'-bis- [(2-phenyl) -benzimidazole] of formula:
H H dont la préparation est décrite dans J. Chim. Phys., 64, 1602 (1967).H H whose preparation is described in J. Chim. Phys., 64, 1602 (1967).
Parmi ces composés organiques insolubles filtrant le rayonnement UV, on préfère tout particulièrement le 2-(lH-benzimidazol-2-yl)benzoxazole, le 6- méthoxy-2,2'-bis-benzimidazole, le 2-(lH-benzimidazol-2-yl)-benzothiazole, le l ,4-phénylène-bis-(2-benzoxazolyle), le l ,4-phénylène-bis-(2- benzimidazolyle), le l,3-phénylène-bis-(2-benzoxazolyle), le 1,2-phénylène- bis-(2-benzoxazolyle), le l,2-phénylène-bis-(2-benzimidazolyle) et le 1,4- phénylène-bis-(N-triméthylsilylméthyl-2-benzimidazoIyle).Among these insoluble organic compounds filtering UV radiation, very particularly preferred is 2- (1H-benzimidazol-2-yl) benzoxazole, 6-methoxy-2,2'-bis-benzimidazole, 2- (1H-benzimidazol- 2-yl) -benzothiazole, 1,4-phenylene-bis- (2-benzoxazolyl) 1,4-phenylene-bis- (2-benzimidazolyl) 1,3-phenylene-bis- (2-benzoxazolyl ), 1,2-phenylene-bis- (2-benzoxazolyl), 1,2-phenylene-bis- (2-benzimidazolyle) and 1,4- phenylene-bis- (N-trimethylsilylmethyl-2-benzimidazoyl) .
Comme indiqué ci-dessus, la taille moyenne des particules insolubles des composés organiques décrits ci-dessus est comprise entre 10 nm et 5 μm.As indicated above, the average size of the insoluble particles of the organic compounds described above is between 10 nm and 5 μm.
Les particules ont de préférence une taille moyenne comprise entre 10 nm et 2 μm, et plus préférentiellement entre 20 nm et 2 μm.The particles preferably have an average size of between 10 nm and 2 μm, and more preferably between 20 nm and 2 μm.
La taille moyenne des particules peut être déterminée par toute méthode classique telle que les méthodes optiques (diffusion quasi-élastique ou diffusion laser), les méthodes par centrifugation ou les méthodes de visualisation microscopique et analyse d'image.The average particle size can be determined by any conventional method such as optical methods (quasi-elastic diffusion or laser diffusion), methods by centrifugation or methods of microscopic visualization and image analysis.
Les filtres organiques insolubles selon l'invention peuvent être amenés sous la forme particulaire ayant la taille moyenne souhaitée par tout moyen approprié, tel qu'un broyage à sec ou en milieu solvant, tamisage, atomisation, micronisation ou pulvérisation. Les filtres organiques insolubles selon l'invention peuvent être en particulier obtenus par un procédé de broyage de particules grossières en présence d'un ou de plusieurs agents tensio-actifs appropriés permettant d'améliorer la dispersion des particules ainsi obtenues dans les formulations cosmétiques.The insoluble organic filters according to the invention can be brought in the particulate form having the desired average size by any suitable means, such as dry grinding or in solvent medium, sieving, atomization, micronization or spraying. The insoluble organic filters according to the invention can in particular be obtained by a process for grinding coarse particles into presence of one or more suitable surfactants making it possible to improve the dispersion of the particles thus obtained in cosmetic formulations.
Un exemple de procédé de réduction de taille des particules de filtres organiques insolubles est décrit dans les documents WO 95/22959 etAn example of a method for reducing the size of particles of insoluble organic filters is described in documents WO 95/22959 and
WO 97/03643. L'appareil de broyage utilisé selon ces documents peut être un broyeur à jet, à billes, à vibration ou à marteau et de préférence un broyeur à haute vitesse d'agitation ou un broyeur à impact et plus particulièrement un broyeur à billes rotatives, un broyeur vibrant, un broyeur à tube ou un broyeur à tige.WO 97/03643. The grinding apparatus used according to these documents can be a jet, ball, vibration or hammer mill and preferably a high agitation mill or an impact mill and more particularly a rotary ball mill, a vibrating crusher, a tube crusher or a rod crusher.
Les composés organiques insolubles filtrant les UV peuvent être utilisés dans des compositions cosmétiques, en particulier des compositions protectrices de l'épiderme humain ou des cheveux, des compositions anti- solaires ou des produits de maquillage.The insoluble organic compounds filtering UV can be used in cosmetic compositions, in particular compositions protecting the human epidermis or the hair, anti-sun compositions or make-up products.
Ces compositions cosmétiques contiennent généralement de 0,1 à 15 % en poids, de préférence de 0,2 à 10 % en poids, par rapport au poids total de la composition cosmétique, de composés organiques insolubles filtrant le rayonnement UV.These cosmetic compositions generally contain from 0.1 to 15% by weight, preferably from 0.2 to 10% by weight, relative to the total weight of the cosmetic composition, of insoluble organic compounds filtering UV radiation.
Les compositions cosmétiques, et en particulier anti-solaires, de la présente invention peuvent contenir en outre un ou plusieurs filtres solaires organiques additionnels, actifs dans le domaine des UV-A et/ou UV-B, différents des filtres insolubles décrits ci-dessus. Ces filtres solaires peuvent être notamment choisis parmi les dérivés cinnamiques, les dérivés de dibenzoylméthane, les dérivés salicyliques, les dérivés du benzylidènecamphre, les dérivés de triazine tels que ceux décrits dans les brevets ou demandes de brevet US 4367 390, EP 0 863 145, EP 0 517 104, EP 0 570 838, EP 0 796 851, EP 0 775 698, EP 0 878 469, EP 0 933 376 et EP 0 893 119, les dérivés de la benzophénone, les dérivés de β,β'- diphénylacrylate, les dérivés de phénylbenzimidazole, les dérivés anthraniliques, les dérivés d'imidazolines, les dérivés de méthylène-bis- (hydroxyphénylbenzotriazole) tels que ceux décrits dans les brevets ou demandes de brevet US 5 237 071, US 5 166 355, GB 2 303 549, DE 19726184 et EP 0 893 119, les dérivés de l'acide p-aminobenzoïque, les polymères hydrocarbonés filtres et les silicones filtres tels que ceux décrits notamment dans la demandé WO 93/04665.The cosmetic, and in particular anti-sun, compositions of the present invention may also contain one or more additional organic sun filters, active in the UV-A and / or UV-B field, different from the insoluble filters described above. . These sunscreens can in particular be chosen from cinnamic derivatives, dibenzoylmethane derivatives, salicylic derivatives, benzylidenecamphor derivatives, triazine derivatives such as those described in patents or patent applications US 4367 390, EP 0 863 145, EP 0 517 104, EP 0 570 838, EP 0 796 851, EP 0 775 698, EP 0 878 469, EP 0 933 376 and EP 0 893 119, benzophenone derivatives, β, β'-diphenylacrylate derivatives , phenylbenzimidazole derivatives, anthranilic derivatives, imidazoline derivatives, methylene-bis- derivatives (hydroxyphenylbenzotriazole) such as those described in patents or patent applications US 5,237,071, US 5,166,355, GB 2,303 549, DE 19726184 and EP 0 893 119, derivatives of p-aminobenzoic acid, screening hydrocarbon polymers and screening silicones such as those described in particular in application WO 93/04665.
On peut citer à titre d'exemples de tels filtres solaires additionnels actifs dans I'UV-A et/ou l'UN-B, les composés suivants désignés par leur nom IΝCI, ainsi que leur mélanges :There may be mentioned as examples of such additional sunscreens active in UV-A and / or UN-B, the following compounds designated by their name IΝCI, as well as their mixtures:
dérivés d'acide para-aminobenzoïque : - PABA - Ethyl PABApara-aminobenzoic acid derivatives: - PABA - Ethyl PABA
- Ethyl Dihydroxypropyl PABA- Ethyl Dihydroxypropyl PABA
- Ethylhexyl Dimethyl PABA vendu notamment sous le nom commercial ESCALOL 507 par ISP, - Glyceryl PABA,- Ethylhexyl Dimethyl PABA sold in particular under the trade name ESCALOL 507 by ISP, - Glyceryl PABA,
- PEG-25 PABA vendu sous le nom commercial UVTΝUL P25 par BASF,- PEG-25 PABA sold under the trade name UVTΝUL P25 by BASF,
dérivés salicyliques :salicylic derivatives:
- Homosalate vendu sous le nom commercial EUSOLEX HMS par ROΝA/EM INDUSTRIES,- Homosalate sold under the trade name EUSOLEX HMS by ROΝA / EM INDUSTRIES,
- Ethylhexyl Salicylate vendu sous le nom commercial NEO HELIOPAN OS par HAARMANN ET REIMER,- Ethylhexyl Salicylate sold under the trade name NEO HELIOPAN OS by HAARMANN ET REIMER,
- Dipropyleneglycol Salicylate vendu sous le nom commercial DIPSAL par SCHER, - TEA Salicylate vendu sous le nom commercial NEO HELIOPAN TS par- Dipropyleneglycol Salicylate sold under the trade name DIPSAL by SCHER, - TEA Salicylate sold under the trade name NEO HELIOPAN TS by
HAARMANN ET REIMER,HAARMANN AND REIMER,
dérivés de dibenzoylméthane :dibenzoylmethane derivatives:
- Butyl Methoxydibenzoylmethane vendu notamment sous le nom commercial PARSOL 1789 par HOFFMANN LAROCHE,- Butyl Methoxydibenzoylmethane sold in particular under the trade name PARSOL 1789 by HOFFMANN LAROCHE,
- Isopropyl Dibenzoylméthane, dérivés cinnamiques :- Isopropyl Dibenzoylmethane, cinnamic derivatives:
- Ethylhexyl Methoxycinnamate vendu notamment sous le nom commercial PARSOL MCX par HOFFMANN LAROCHE,- Ethylhexyl Methoxycinnamate sold in particular under the trade name PARSOL MCX by HOFFMANN LAROCHE,
- Isopropyl Methoxycinnamate - Isoamyl Methoxycinnamate vendu sous le nom commercial NEO- Isopropyl Methoxycinnamate - Isoamyl Methoxycinnamate sold under the trade name NEO
HELIOPAN E 1000 par HAARMANN ET REIMER,HELIOPAN E 1000 by HAARMANN AND REIMER,
- Cinoxate,- Cinoxate,
- DEA Methoxycinnamate,- DEA Methoxycinnamate,
- Diisopropyl Methylcinnamate, - Glyceryl Ethylhexanoate Dimethoxycinnamate- Diisopropyl Methylcinnamate, - Glyceryl Ethylhexanoate Dimethoxycinnamate
dérivés de β.β-diphénylacrylate :β.β-diphenylacrylate derivatives:
- Octocrylene vendu notamment sous le nom commercial UVINUL-539 par BASF, - Etocrylene vendu notamment sous le nom commercial UVINUL N-35 par- Octocrylene sold in particular under the trade name UVINUL-539 by BASF, - Etocrylene sold in particular under the trade name UVINUL N-35 by
BASF,BASF
dérivés de benzophénone :benzophenone derivatives:
- Benzophénone- 1 vendue sous le nom commercial UVINUL 400 par BASF, - Benzophenone-2 vendue sous le nom commercial UVINUL D-50 par- Benzophenone-1 sold under the trade name UVINUL 400 by BASF, - Benzophenone-2 sold under the trade name UVINUL D-50 by
BASF,BASF
- Benzophenone-3 ou Oxybenzone vendue sous le nom commercial UVINUL M-40 par BASF,- Benzophenone-3 or Oxybenzone sold under the trade name UVINUL M-40 by BASF,
- Benzophenone-4 vendue sous le nom commercial UVINUL MS-40 par BASF,- Benzophenone-4 sold under the trade name UVINUL MS-40 by BASF,
- Benzophenone-5,- Benzophenone-5,
- Benzophenone-6 vendue sous le nom commercial HELISORB 11 par NORQUAY,- Benzophenone-6 sold under the trade name HELISORB 11 by NORQUAY,
- Benzophenone-8 vendue sous le nom commercial SPECTRA-SORB UV- 24 par AMERICAN CYANAMID- Benzophenone-8 sold under the trade name SPECTRA-SORB UV- 24 by AMERICAN CYANAMID
- Benzophenone-9 vendue sous le nom commercial UVINUL DS-49 par BASF,- Benzophenone-9 sold under the trade name UVINUL DS-49 by BASF,
- Benzophénone- 12 dérivés du benzylidène camphre :- Benzophenone- 12 benzylidene camphor derivatives:
- 3-Benzylidene Camphor fabriqué sous le nom MEXORYL SD par CHIMEX,- 3-Benzylidene Camphor manufactured under the name MEXORYL SD by CHIMEX,
- 4-Methylbenzylidene Camphor vendu notamment sous le nom commercial EUSOLEX 6300 par MERCK,- 4-Methylbenzylidene Camphor sold in particular under the trade name EUSOLEX 6300 by MERCK,
- Benzylidène Camphor Sulfonic Acid fabriqué sous le nom MEXORYL SL par CHIMEX,- Benzylidene Camphor Sulfonic Acid manufactured under the name MEXORYL SL by CHIMEX,
- Camphor Benzalkonium Methosulfate fabriqué sous le nom MEXORYL SO par CHIMEX, - Terephthalylidene Dicamphor Sulfonic Acid fabriqué sous le nom- Camphor Benzalkonium Methosulfate produced under the name MEXORYL SO by CHIMEX, - Terephthalylidene Dicamphor Sulfonic Acid produced under the name
MEXORYL SX par CHIMEX,MEXORYL SX by CHIMEX,
- Polyacrylamidomethyl Benzylidène Camphor fabriqué sous le nom MEXORYL S W par CHIMEX,- Polyacrylamidomethyl Benzylidene Camphor manufactured under the name MEXORYL S W by CHIMEX,
dérivés de phénylbenzimidazole :phenylbenzimidazole derivatives:
- Phenylbenzimidazole Sulfonic Acid vendu notamment sous le nom commercial EUSOLEX 232 par MERCK- Phenylbenzimidazole Sulfonic Acid sold in particular under the trade name EUSOLEX 232 by MERCK
- Benzimidazilate vendu sous le nom commercial NEO HELIOPAN AP par HAARMANN ET REIMER- Benzimidazilate sold under the trade name NEO HELIOPAN AP by HAARMANN ET REIMER
dérivés de triazine :triazine derivatives:
- Anisotriazine vendue sous le nom commercial TLNOSORB S par CIBA GEIGY- Anisotriazine sold under the trade name TLNOSORB S by CIBA GEIGY
- Ethylhexyl triazone vendue notamment sous le nom commercial UVINUL T150 par BASF,- Ethylhexyl triazone sold in particular under the trade name UVINUL T150 by BASF,
- Diéthylhexyl Butamido Triazone yendue sous le nom commercial UVASORB HEB par SIGMA 3V,- Diethylhexyl Butamido Triazone with the trade name UVASORB HEB by SIGMA 3V,
dérivés de phénylbenzotriazole : - Drometrizole Trisiloxane vendu sous le nom commercial SILATRIZOLE par RHODIA CHIMIE,phenylbenzotriazole derivatives: - Drometrizole Trisiloxane sold under the trade name SILATRIZOLE by RHODIA CHIMIE,
- Méthylène bis-Benzotriazolyl Tetramethylbutylphenol vendu sous forme solide sous le nom commercial MIXXIM BB/100 par FAIRMOUNT CHEMICAL ou sous forme micronisée en dispersion aqueuse sous le nom commercial TINOSORB M par CIB A SPECIALTY CHEMICALS,- Methylene bis-Benzotriazolyl Tetramethylbutylphenol sold in solid form under the trade name MIXXIM BB / 100 by FAIRMOUNT CHEMICAL or in micronized form in aqueous dispersion under the trade name TINOSORB M by CIB A SPECIALTY CHEMICALS,
dérivés anthraniliques : - Menthyl Anthranilate vendu sous le nom commercial NEO HELIOPANanthranilic derivatives: - Menthyl Anthranilate sold under the trade name NEO HELIOPAN
MA par HAARMAN ET REIMER,MA by HAARMAN AND REIMER,
dérivés d'imidazolines :imidazoline derivatives:
- Ethylhexyl Dimethoxybenzylidene Dioxoimidazoline Propionate- Ethylhexyl Dimethoxybenzylidene Dioxoimidazoline Propionate
dérivés du benzalmalonate :benzalmalonate derivatives:
- Polyorganosiloxane à fonctions benzalmalonate vendu sous le nom commercial PARSOL SLX par HOFFMANN LAROCHE- Benzalmalonate-functional polyorganosiloxane sold under the trade name PARSOL SLX by HOFFMANN LAROCHE
Les filtres UV organiques plus particulièrement préférés sont choisis parmi les composés suivants :The more particularly preferred organic UV filters are chosen from the following compounds:
- Ethylhexyl Salicylate,- Ethylhexyl Salicylate,
- Butyl Methoxydibenzoylmethane,- Butyl Methoxydibenzoylmethane,
- Ethylhexyl Methoxycinnamate, - Octocrylene,- Ethylhexyl Methoxycinnamate, - Octocrylene,
- Phenylbenzimidazole Sulfonic Acid,- Phenylbenzimidazole Sulfonic Acid,
- Terephthalylidene Dicamphor Sulfonic Acid,- Terephthalylidene Dicamphor Sulfonic Acid,
- Benzophenone-3,- Benzophenone-3,
- Benzophenone-4, - Benzophenone-5,- Benzophenone-4, - Benzophenone-5,
- 4-Methylbenzylidene Camphor,- 4-Methylbenzylidene Camphor,
- Benzimidazilate,- Benzimidazilate,
- Anisotriazine,- Anisotriazine,
- Ethylhexyl Triazone, - Diéthylhexyl Butamido Triazone,- Ethylhexyl Triazone, - Diethylhexyl Butamido Triazone,
- Méthylène bis-Benzotriazolyl Tetramethylbutylphenol,- Methylene bis-Benzotriazolyl Tetramethylbutylphenol,
- Drometrizole Trisiloxane, et leurs mélanges. Les compositions cosmétiques selon l'invention peuvent contenir en outre des agents de bronzage et/ou de brunissage artificiel de la peau (agents autobronzants) tels que la dihydroxy acétone (DH A).- Drometrizole Trisiloxane, and their mixtures. The cosmetic compositions according to the invention may also contain agents for artificial tanning and / or browning of the skin (self-tanning agents) such as dihydroxy acetone (DH A).
Les compositions cosmétiques selon l'invention peuvent contenir en outre un ou plusieurs pigments minéraux et en particulier des nanopigments d'oxydes métalliques, enrobés ou non, comme par exemple les nanopigments d'oxyde de titane sous forme amorphe ou cristallisée (rutile et/ou anatase), d'oxyde de fer, d'oxyde de zinc, d'oxyde de zirconium ou d'oxyde de cérium. Ces nanopigments ont une taille moyenne de particules comprise entre 5 nm etThe cosmetic compositions according to the invention may also contain one or more mineral pigments and in particular nanopigments of metal oxides, coated or not, such as for example titanium oxide nanopigments in amorphous or crystallized form (rutile and / or anatase), iron oxide, zinc oxide, zirconium oxide or cerium oxide. These nanopigments have an average particle size of between 5 nm and
100 nm, de préférence entre 10 nm et 50 nm et sont tous des agents photoprotecteurs UV connus.100 nm, preferably between 10 nm and 50 nm and are all known UV photoprotective agents.
Ces nanopigments peuvent être enrobés par des agents d'enrobage connus comme par exemple l'alumine et/ou le stéarate d'aluminium. De tels nanopigments enrobés ou non enrobés sont décrits par exemple dans les demandes de brevets EP-A-0 518 772 et EP-A-0 518 773.These nanopigments can be coated with known coating agents such as, for example, alumina and / or aluminum stearate. Such coated or uncoated nanopigments are described, for example, in patent applications EP-A-0 518 772 and EP-A-0 518 773.
Les compositions cosmétiques peuvent contenir en outre des adjuvants de formulation usuels tels que les corps gras, les solvants organiques physiologiquement acceptables, les silicones, les agents tensioactifs, les polymères anioniques, cationiques, non ioniques, amphotères ou leurs mélanges, les agents épaississants, les agents antioxydants, les agents opacifiants, les agents stabilisants, les agents anti-mousse, les parfums, les agents conservateurs, les charges, les agents séquestrants, les agents propulseurs, les agents d'ajustement du pH, les colorants et leurs mélanges.The cosmetic compositions may also contain usual adjuvants of formulation such as fatty substances, physiologically acceptable organic solvents, silicones, surfactants, anionic, cationic, nonionic, amphoteric polymers or their mixtures, thickening agents, antioxidants, clouding agents, stabilizers, defoamers, fragrances, preservatives, fillers, sequestering agents, propellants, pH adjusting agents, dyes and mixtures thereof.
Elles peuvent contenir en outre un ou plusieurs principes actifs cosmétiques choisis par exemple parmi les agents adoucissants, les hydroxyacides, les vitamines, les agents hydratants, les agents émollients, les agents anti-radicalaires, les antagonistes de substance P, les agents anti- inflammatoires et des mélanges de ces composés.They can also contain one or more cosmetic active ingredients chosen, for example, from softening agents, hydroxy acids, vitamins, hydrating agents, emollient agents, anti-free radical agents, substance P antagonists, anti-inflammatory agents. and mixtures of these compounds.
Les corps gras peuvent être constitués par une huile ou une cire ou leurs mélanges, et ils comprennent également les acides gras, les alcools gras et les esters d'acides gras. Les huiles peuvent être choisies parmi les huiles animales, végétales, minérales ou de synthèse et notamment parmi l'huile de vaseline, l'huile de paraffine, les huiles de silicone, volatiles ou non, les isoparaffines, les polyoléfines, les huiles fluorées et perfluorées. De même, les cires peuvent être choisies parmi les cires animales, fossiles, végétales, minérales ou de synthèse connues en soi. Parmi les solvants organiques, on peut citer les alcools et polyols inférieurs tels que l'éthanol, l'isopropanol, le propylèneglycol, la glycérine et le sorbitol.The fatty substances can be constituted by an oil or a wax or their mixtures, and they also include fatty acids, fatty alcohols and fatty acid esters. The oils can be chosen from animal, vegetable, mineral or synthetic oils and in particular from petrolatum, paraffin oil, silicone oils, volatile or not, isoparaffins, polyolefins, fluorinated and perfluorinated oils. Likewise, the waxes can be chosen from animal, fossil, vegetable, mineral or synthetic waxes known per se. Among the organic solvents, mention may be made of lower alcohols and polyols such as ethanol, isopropanol, propylene glycol, glycerin and sorbitol.
Les épaississants peuvent être choisis notamment parmi les gommes de guar et celluloses, modifiées ou non, telles que la gomme de guar hydroxypropylée, la méthylhydroxyéthylcellulose, l'hydroxypropylméthyl- cellulose ou encore l'hydroxyéthylcellulose.The thickeners may be chosen in particular from guar gums and celluloses, modified or not, such as hydroxypropylated guar gum, methylhydroxyethylcellulose, hydroxypropylmethylcellulose or also hydroxyethylcellulose.
Bien entendu l'homme du métier veillera à choisir ce ou ces éventuels composés complémentaires et/ou leurs quantités de manière à ce que les propriétés avantageuses intrinsèques à l'invention, et en particulier l'insolubilité des agents filtrant le rayonnement UV, ne soient pas altérées par la ou les adjonctions envisagées.Of course, a person skilled in the art will take care to choose this or these optional additional compounds and / or their quantities so that the advantageous properties intrinsic to the invention, and in particular the insolubility of the agents screening out UV radiation, are not not altered by the planned addition (s).
Les compositions de l'invention peuvent être préparées selon les techniques bien connues de l'homme du métier, en particulier celles destinées à la préparation d'émulsions de type huile-dans-eau ou eau-dans-huile.The compositions of the invention can be prepared according to techniques well known to those skilled in the art, in particular those intended for the preparation of emulsions of the oil-in-water or water-in-oil type.
Cette composition peut se présenter en particulier sous forme d'émulsion, simple ou complexe (H/E, E/H, H E/H ou E/H/E) telle qu'une crème, un lait, un gel ou un gel-crème, de poudre ou de bâtonnet solide, et peuvent éventuellement être conditionnée en aérosol et se présenter sous forme de mousse ou de spray.This composition can be in particular in the form of an emulsion, simple or complex (O / W, W / O, HE / O or W / O / W) such as a cream, a milk, a gel or a gel- cream, powder or solid stick, and can optionally be packaged as an aerosol and come in the form of a foam or spray.
Lorsqu'il s'agit d'une émulsion, la phase aqueuse de celle-ci peut comprendre une dispersion vésiculaire non ionique préparée selon des procédés connus (Bangham, Standish and Watkins, J. Mol. Biol. 13, 238 (1965), FR 2 315 991 et FR 2 416 008).When it is an emulsion, the aqueous phase thereof may comprise a nonionic vesicular dispersion prepared according to known methods (Bangham, Standish and Watkins, J. Mol. Biol. 13, 238 (1965), FR 2 315 991 and FR 2 416 008).
La composition cosmétique de l'invention peut être utilisée comme composition protectrice de l'épiderme humain ou des cheveux contre les rayons ultraviolets, comme composition anti-solaire ou comme produit de maquillage. Lorsque la composition cosmétique selon l'invention est utilisée pour la protection de l'épidémie humain contre les rayons UV, ou comme composition antisolaire, elle peut se présenter sous forme de suspension ou de dispersion dans des solvants ou des corps gras, sous forme de dispersion vésiculaire non ionique ou encore sous forme d'émulsion, de préférence de type huile-dans-eau, telle qu'une crème ou un lait, sous forme de pommade, de gel, de gel crème, de bâtonnet solide, de stick, de poudre, de mousse aérosol ou de spray.The cosmetic composition of the invention can be used as a composition for protecting the human epidermis or the hair against ultraviolet rays, as an anti-sun composition or as a make-up product. When the cosmetic composition according to the invention is used for the protection of the human epidemic against UV rays, or as an antisun composition, it may be in the form of a suspension or of dispersion in solvents or fatty substances, in the form of nonionic vesicular dispersion or alternatively in the form of an emulsion, preferably of the oil-in-water type, such as a cream or a milk, in the form of an ointment, gel, cream gel, solid stick, stick, powder, aerosol foam or spray.
Lorsque la composition cosmétique selon l'invention est utilisée pour la protection des cheveux contre les rayons UV, elle peut se présenter sous forme de shampooing, de lotion, de gel, d'émulsion, de dispersion vésiculaire non ionique et constituer par exemple une composition à rincer, à appliquer avant ou après shampoooing, avant ou après coloration ou décoloration, avant, pendant ou après permanente ou défrisage, une lotion ou un gel coiffants ou traitants, une lotion ou un gel pour le brushing. ou la mise en plis, une composition de permanente ou dé défrisage, de coloration ou de décoloration des cheveux.When the cosmetic composition according to the invention is used for protecting the hair against UV rays, it can be in the form of a shampoo, lotion, gel, emulsion, nonionic vesicular dispersion and constitute, for example, a composition to rinse, apply before or after shampooing, before or after coloring or discoloration, before, during or after permanent or straightening, a styling or treating lotion or gel, a brushing lotion or gel. or styling, a composition of permanent or straightening, coloring or bleaching of the hair.
Lorsque la composition est utilisée comme produit de maquillage des cils, des sourcils ou de la peau, tel que crème de traitement de l'épiderme, fond de tein, bâton de rouge à lèvres, fard à paupières, fard à joues, mascara ou ligneur encore appelé "eye-liner", elle peut se présenter sous forme solide ou pâteuse, anhydre ou aqueuse, comme des émulsions huile-dans-eau ou eau- dans-huile, des dispersions vésiculaires non ioniques ou encore des suspensions. A titre indicatif, pour les formulations anti-solaires conformes à l'invention, qui présentent un support de type émulsion huile-dans-eau, la phase aqueuse représente généralement de 50 à 95 % en poids, de préférence de 70 à 90 % en poids, par rapport à l'ensemble de la formulation, la phase huileuse de 5 à 50 % en poids, de préférence de 10 à 30 % en poids, par rapport à l'ensemble de la formulation, et le ou les (co)émulsionnant(s) de 0,5 àWhen the composition is used as a makeup product for the eyelashes, the eyebrows or the skin, such as an epidermis treatment cream, a foundation of lipstick, a lipstick stick, eyeshadow, blush, mascara or liner also called "eyeliner", it can be in solid or pasty, anhydrous or aqueous form, such as oil-in-water or water-in-oil emulsions, nonionic vesicular dispersions or suspensions. As an indication, for the anti-sun formulations in accordance with the invention, which have an oil-in-water emulsion type support, the aqueous phase generally represents from 50 to 95% by weight, preferably from 70 to 90% by weight. weight, relative to the entire formulation, the oily phase of 5 to 50% by weight, preferably 10 to 30% by weight, relative to the entire formulation, and the (co) emulsifier (s) from 0.5 to
20 % en poids, de préférence de 2 à 10 % en poids, par rapport à l'ensemble de la formulation. Les agents filtrants insolubles de la présente invention peuvent également être utilisés pour protéger des matériaux, comme des verres organiques ou minéraux ou les matières plastiques, sensibles au rayonnement20% by weight, preferably from 2 to 10% by weight, relative to the whole of the formulation. The insoluble filtering agents of the present invention can also be used to protect materials, such as organic or mineral glasses or plastics, sensitive to radiation.
UV, en particulier au rayonnement solaire. Les particules sont alors appliquées sur ou incorporées dans le matériau à protéger en une quantité efficace.UV, especially solar radiation. The particles are then applied to or incorporated into the material to be protected in an effective amount.
L'invention a aussi pour objet un procédé non-thérapeutique de protection de la peau et/ou des cheveux contre le rayonnement ultraviolet, en particulier le rayonnement solaire, qui consiste à appliquer sur la peau ou les cheveux une quantité efficace de la composition cosmétique définie ci-dessus, ou d'un composé de formule (I), (II) ou (III) tel que défini ci-avant.The subject of the invention is also a non-therapeutic process for protecting the skin and / or the hair against ultraviolet radiation, in particular solar radiation, which consists in applying to the skin or the hair an effective amount of the cosmetic composition. defined above, or of a compound of formula (I), (II) or (III) as defined above.
L'invention a enfin pour objet un procédé non-thérapeutique de contrôle de la variation de couleur de la peau due au rayonnement UV, qui consiste à appliquer sur la peau une quantité efficace de la composition cosmétique définie ci-dessus, ou d'un composé de formule (I), (II) ou (III) tel que défini ci-avant.The invention finally relates to a non-therapeutic process for controlling the variation in skin color due to UV radiation, which consists in applying to the skin an effective amount of the cosmetic composition defined above, or of a compound of formula (I), (II) or (III) as defined above.
Les exemples suivants illustrent l'invention.The following examples illustrate the invention.
Exemples de composésExamples of compounds
Exemple 1Example 1
Synthèse du l,4-phénylène-bis-(2-benzoxazolyle)Synthesis of 1,4-phenylene-bis- (2-benzoxazolyl)
On chauffe un mélange hétérogène constitué de 50 g (0,3 mole) d'acide téréphtalique, de 131 g (1,2 moles) de 2-aminophénol, de 1,2 g d'acide borique et de 360 g d'acide polyphosphorique, pendant 4 heures sous atmosphère d'azote et agitation à une température comprise entre 190 etA heterogeneous mixture is heated consisting of 50 g (0.3 mole) of terephthalic acid, 131 g (1.2 moles) of 2-aminophenol, 1.2 g of boric acid and 360 g of acid polyphosphoric, for 4 hours under a nitrogen atmosphere and stirring at a temperature between 190 and
205 °C. Après refroidissement à environ 100 °C, on verse le mélange sur 2,5 litres d'eau glacée. On recueille le précipité par filtration, on lave avec une solution aqueuse de carbonate de sodium à 5 % jusqu'à ce que l'eau de lavage soit à pH basique, puis à l'eau jusqu'à ce que l'eau de lavage ait un pH voisin de la neutralité. Après recristallisation du solide obtenu dans de la N- méthylpyrrolidone et séchage, on obtient 76,1 g de l,4-phénylène-bis-(2- benzoxazolyle) (rendement 81 %) sous forme d'une poudre de couleur jaune pâle.205 ° C. After cooling to about 100 ° C, the mixture is poured into 2.5 liters of ice water. The precipitate is collected by filtration, washed with a 5% aqueous sodium carbonate solution until the washing water is at basic pH, then with water until the washing water has a pH close to neutral. After recrystallization of the solid obtained from N-methylpyrrolidone and drying, 76.1 g of 1,4-phenylene-bis- (2-benzoxazolyl) are obtained (yield 81%) in the form of a pale yellow powder.
Analyse élémentaire pour C20H12N2O2 : calculé : C 76,91 ; H 3,87 ; N 8,97 trouvé : C 76,50 ; H 3,98 ; N 8,99Elementary analysis for C 20 H 12 N 2 O 2 : calculated: C 76.91; H 3.87; N 8.97 found: C 76.50; H 3.98; N 8.99
Préparation d'une dispersion aqueuse du filtre :Preparation of an aqueous dispersion of the filter:
Sous une agitation moyenne à l'aide d'un agitateur muni d'une défloculeuse, on introduit de petites fractions du filtre insoluble obtenu sous forme de poudre dans un mélange, préalablement homogénéisé, d'eau et de 7,5 % d'un alkylpolyglucoside commercialisé sous la dénominationSmall fractions of the insoluble filter obtained in the form of powder are introduced into a mixture, previously homogenized, of water and 7.5% of the mixture, with moderate stirring using a stirrer equipped with a deflocculator. alkylpolyglucoside marketed under the name
PLANTAREN® par la société HENKEL. On laisse sous agitation pendant 45 minutes, en veillant à ne pas introduire de l'air dans la suspension.PLANTAREN ® by the company HENKEL. The mixture is left stirring for 45 minutes, taking care not to introduce air into the suspension.
Broyage : On introduit la prédispersion obtenue par pompage dans le bolGrinding: The predispersion obtained by pumping is introduced into the bowl
(capacité 150 ml) d'un broyeur à billes de type Dyno-Mill commercialisé par la société WAB, rempli jusqu'à 80 % de sa capacité de billes de verre de 1 mm de diamètre. Le broyage est réalisé en circuit fermé pendant 2 heures 30 minutes avec circulation d'eau pour éviter un échauffement de la préparation. La dispersion obtenue est stabilisée à l'aide de gomme de xanthane. Le broyage peut également s'effectuer avec circulation de la dispersion en continu pendant tout le temps du broyage.(capacity 150 ml) of a Dyno-Mill type ball mill marketed by the company WAB, filled up to 80% of its capacity with glass beads of 1 mm in diameter. Grinding is carried out in a closed circuit for 2 hours 30 minutes with circulation of water to avoid overheating of the preparation. The dispersion obtained is stabilized using xanthan gum. The grinding can also be carried out with circulation of the dispersion continuously during the entire grinding time.
Le diamètre moyen de la distribution en nombre pour l'échantillon ainsi obtenu, déterminé à l'aide d'un appareil Mastersizer 2000 de la sociétéThe average diameter of the number distribution for the sample thus obtained, determined using a Mastersizer 2000 device from the company
MALVERN, est de 0,450 μm. Le profil granulométrique est présenté sur la figure 1 du dessin annexé. Exemple 2MALVERN, is 0.450 μm. The particle size profile is shown in Figure 1 of the accompanying drawing. Example 2
Synthèse du 1.4-phénylène-bis-(2-benzimidazolyle)Synthesis of 1,4-phenylene-bis- (2-benzimidazolyl)
On chauffe un mélange hétérogène de 66,4 g (0,4 mole) d'acide téréphtalique, de 199 g (1,84 mole) d'ortho-phénylènediamine, de 6 g d'acide borique et de 50 ml de N-méthylpyrrolidone pendant quelques minutes sous atmosphère d'azote à une température de 70 - 80 °C, puis, sous barbotage d'azote, on chauffe le mélange à 190 - 200 °C, et on le maintient pendant 5 heures à cette température. L'eau formée distille et est recueillie par la rampe de distillation. On laisse le mélange refroidir jusqu'à environ 100 °C et on y ajoute avec précaution 135 ml de N-méthylpyrrolidone. On refroidit jusqu'à 20 °C, on sépare le solide obtenu par filtration et on le lave avec de la N- méthylpyrrolidone, puis avec un mélange de N-méthylpyrrolidone/éthanolA heterogeneous mixture of 66.4 g (0.4 mole) of terephthalic acid, 199 g (1.84 mole) of ortho-phenylenediamine, 6 g of boric acid and 50 ml of N- is heated. methylpyrrolidone for a few minutes under a nitrogen atmosphere at a temperature of 70 - 80 ° C, then, with nitrogen bubbling, the mixture is heated to 190 - 200 ° C, and maintained for 5 hours at this temperature. The water formed distills and is collected by the distillation ramp. The mixture is allowed to cool to about 100 ° C and 135 ml of N-methylpyrrolidone is carefully added to it. Cool to 20 ° C, separate the solid obtained by filtration and wash with N-methylpyrrolidone, then with a mixture of N-methylpyrrolidone / ethanol
(50/50). Après séchage, on obtient 97 g de l,4-phénylène-bis-(2- benzimidazolyle) (rendement 78 %) sous forme d'une poudre blanche.(50/50). After drying, 97 g of 1,4-phenylene-bis- (2-benzimidazolyl) are obtained (yield 78%) in the form of a white powder.
Analyse élémentaire pour C2oH14N : calculé : C 77,40 ; H 4,55 ; N 18,05 trouvé : C 77,18 ; H 4,87 ; N 17,95Elementary analysis for C 2 oH 14 N: calculated: C 77.40; H 4.55; N 18.05 found: C 77.18; H 4.87; N 17.95
Préparation d'une dispersion aqueuse du filtre : Sous une agitation moyenne à l'aide d'un agitateur muni d'une défloculeuse, on introduit de petites fractions du filtre insoluble obtenu sous forme de poudre dans un mélange, préalablement homogénéisé, d'eau et de 7,5 % d'un alkylpolyglucoside commercialisé sous la dénomination PLANTAREN® par la société HENKEL. On laisse sous agitation pendant 45 minutes, en veillant à ne pas introduire de l'air dans la suspension. Broyage :Preparation of an aqueous dispersion of the filter: With moderate stirring using a stirrer fitted with a deflocculator, small fractions of the insoluble filter obtained in powder form are introduced into a mixture, previously homogenized, of water. and 7.5% of an alkylpolyglucoside marketed under the name Plantaren ® by the company Henkel. The mixture is left stirring for 45 minutes, taking care not to introduce air into the suspension. Grinding :
On introduit la prédispersion obtenue par pompage dans le bol (capacité 150 ml) d'un broyeur à billes de type Dyno-Mill commercialisé par la société WAB, rempli jusqu'à 80 % de sa capacité de billes de verre de 1 mm de diamètre. Le broyage est réalisé en circuit fermé pendant 2 heures 30 minutes avec circulation d'eau pour éviter un échauffement de la préparation. La dispersion obtenue est stabilisée à l'aide de gomme de xanthane. Le broyage peut également s'effectuer avec circulation de la dispersion en continu pendant tout le temps du broyage.The predispersion obtained by pumping is introduced into the bowl (capacity 150 ml) of a Dyno-Mill type ball mill marketed by the company WAB, filled up to 80% of its capacity with glass beads of 1 mm in diameter . Grinding is carried out in a closed circuit for 2 hours 30 minutes with circulation of water to avoid overheating of the preparation. The dispersion obtained is stabilized using xanthan gum. The grinding can also be carried out with circulation of the dispersion continuously during the entire grinding time.
Le diamètre moyen de la distribution en nombre pour l'échantillon ainsi obtenu, déterminé à l'aide d'un appareil Mastersizer 2000 de la société MALVERN, est de 0,450 μm. Le profil granulométrique est présenté sur la figure 2 du dessin annexé. The average diameter of the number distribution for the sample thus obtained, determined using a Mastersizer 2000 device from the company MALVERN, is 0.450 μm. The particle size profile is shown in Figure 2 of the accompanying drawing.
Exemples de compositions cosmétiquesExamples of cosmetic compositions
Exemple A Crème (émulsion huile-dans-eau)Example A Cream (oil-in-water emulsion)
Mélange de mono- et distéarate de glycérol/stéarate de PEG (100 OE)*Mixture of glycerol mono- and distearate / PEG stearate (100 EO) *
(ARLACEL® 165FL de ICI) 2 g(ARLACEL ® 165FL from HERE) 2 g
Alcool stéarylique (LANETTE® 18 de HENKEL) 1 gStearyl alcohol (LANETTE ® 18 from HENKEL) 1 g
Acide stéarique d'huile de palmePalm oil stearic acid
(STEARINE® TP de STEARINERIE DUBOIS) 2,5 g(STEARINE ® TP from STEARINERIE DUBOIS) 2.5 g
Polydiméthylsiloxanepolydimethylsiloxane
(DOW CORNING 200 FLUID® de DOW CORNING 0,5 g Benzoate d'alcools en C12/15 (DOW CORNING 200 FLUID ® from DOW CORNING 0.5 g Benzoate of C 12/15 alcohols
(WITCONOL® TN de WITCO) 20 g(WITCONOL ® TN from WITCO) 20 g
Triéthanolamine 0,5 gTriethanolamine 0.5 g
Dispersion aqueuse à 38 % de l,4-Phénylène-bis-(2-benzoxazolyle) préparé selon l'exemple 1 13,2 g Glycérine 4 g38% aqueous dispersion of 1,4-Phenylene-bis- (2-benzoxazolyl) prepared according to Example 1 13.2 g Glycerin 4 g
Phosphate d'alcool hexadécylique, sel de potassiumHexadecyl alcohol phosphate, potassium salt
(AMPHISOL® K de HOFFMANN LAROCHE) 0,5 g(AMPHISOL ® K from HOFFMANN LAROCHE) 0.5 g
Triéthanolamine 0,3 gTriethanolamine 0.3 g
Poly(acide acrylique) (SYNTHALEN® K de 3V) 0,3 gPoly (acrylic acid) (SYNTHALEN ® K 3V) 0.3 g
Conservateur q.s.Curator q.s.
Eau déminéralisée q.s.p. 100 gDemineralized water q.s.p. 100g
* PEG : polyéthylèneglycol, OE : motifs d'oxyde d'éthylène* PEG: polyethylene glycol, OE: ethylene oxide units
On chauffe séparément la phase grasse et la phase aqueuse à 70 °C, puis on introduit la phase huileuse dans la phase aqueuse sous agitation. On maintient l'agitation pendant environ 15 minutes et on laisse refroidir sous agitation lente jusqu'à retour de la composition à température ambiante.The fatty phase and the aqueous phase are heated separately to 70 ° C., then the oily phase is introduced into the aqueous phase with stirring. Stirring is continued for approximately 15 minutes and allowed to cool with slow stirring until the composition returns to room temperature.
L'efficacité de cette composition est évaluée in vitro à l'aide d'un spectroradiomètre de type SPF 290 commercialisé par la société Optometrics et selon la méthode de Diffey et Robson (B.L. Diffey et al., J. Soc. Cosmet. Chem., 40, 127 - 133 (1989)) sur plaque de quartz revêtue d'un ruban Transpore®. Le facteur de protection solaire (FPS) est égal à 6,1 ± 0,8. Exemple BThe effectiveness of this composition is evaluated in vitro using a spectroradiometer of the SPF 290 type sold by the company Optometrics and according to the method of Diffey and Robson (BL Diffey et al., J. Soc. Cosmet. Chem. , 40, 127 - 133 (1989)) on quartz plate coated with Transpore ® tape. The sun protection factor (SPF) is 6.1 ± 0.8. Example B
(Crème huile-dans-eau)(Oil-in-water cream)
Mélange d'alcool cétylstéarylique et d'alcool cétylstéarylique oxyéthyléné (33 OE) 80/20Mixture of cetylstearyl alcohol and oxyethylenated cetylstearyl alcohol (33 EO) 80/20
(SLNNOWAX® AO de HENKEL) 7 g(HENKEL SLNNOWAX ® AO) 7 g
Mélange de mono- et distéarate de glycérolMixture of glycerol mono- and distearate
(CERASYNT® SD-V de ISP) 2 g Alcool cétylique 1,5 g(CERASYNT ® SD-V from ISP) 2 g Cetyl alcohol 1.5 g
Polydiméthylsiloxanepolydimethylsiloxane
(DOW CORNING 200 FLUID® de DOW CORNING 1,5 g(DOW CORNING 200 FLUID ® from DOW CORNING 1.5 g
Huile de vaseline 15 gVaseline oil 15 g
Dispersion aqueuse à 10 % en poids de l,4-Phénylène-bis-(2-benzimidazolyle) préparé selon l'exemple 2 50 gAqueous dispersion at 10% by weight of 1,4-phenylene-bis- (2-benzimidazolyl) prepared according to example 2 50 g
Conservateur q.s.Curator q.s.
Eau déminéralisée q.s.p. 100 gDemineralized water q.s.p. 100g
On prépare la crème huile-dans-eau de la manière décrite dans l'exemple A.The oil-in-water cream is prepared as described in Example A.
L'efficacité de cette composition est évaluée in vitro à l'aide d'un spectroradiomètre de type SPF 290 commercialisé par la société Optometrics et selon la méthode de Diffey et Robson (B.L. Diffey et al, J. Soc Cosmet. Chem., 40, 127 - 133 (1989)) sur plaque de quartz revêtue d'un ruban Transpore®. Le facteur de protection solaire (FPS) est égal à 7,6 ± 1,5. The effectiveness of this composition is evaluated in vitro using a spectroradiometer of the SPF 290 type sold by the company Optometrics and according to the method of Diffey and Robson (BL Diffey et al, J. Soc Cosmet. Chem., 40 , 127 - 133 (1989)) on quartz plate coated with Transpore ® tape. The sun protection factor (SPF) is equal to 7.6 ± 1.5.
Exemple CExample C
(Crème huile-dans-eau)(Oil-in-water cream)
Mélange de mono- et distéarate de glycérol/stéarate de PEG (100 OE)*Mixture of glycerol mono- and distearate / PEG stearate (100 EO) *
(ARLACEL® 165FL de ICI) 2 g(ARLACEL ® 165FL from HERE) 2 g
Alcool stéaryliqueStearyl alcohol
(L ANETTE® 18 de HENKEL) 1 g Acide stéarique d'huile de palme(L ANETTE ® 18 from HENKEL) 1 g Stearic acid from palm oil
(STEARINE® TP de STEARTNERIE DUBOIS) 2,5 g(STEARINE ® TP from STEARTNERIE DUBOIS) 2.5 g
Polydiméthylsiloxanepolydimethylsiloxane
(DOW CORNING 200 FLUID® de DOW CORNING 0,5 g(DOW CORNING 200 FLUID ® from DOW CORNING 0.5 g
Benzoate d'alcools en C12 15 (WITCONOL® TN de WITCO) 20 gC 12 15 alcohol benzoate (WITCONOL ® TN from WITCO) 20 g
Triéthanolamine 0,5 gTriethanolamine 0.5 g
Dispersion aqueuse à 10 % en poids de l,4-Phénylène-bis-(2-benzimidazolyle) préparé selon l'exemple 2 50 gAqueous dispersion at 10% by weight of 1,4-phenylene-bis- (2-benzimidazolyl) prepared according to example 2 50 g
Glycérine 4 g Triéthanolamine 0,3 gGlycerin 4 g Triethanolamine 0.3 g
Poly(acide acrylique)Poly (acrylic acid)
(SYNTHALEN® K de 3V) 0,3 g(SYNTHALEN ® K of 3V) 0.3 g
Hydroxypropylméthylcellulosehydroxypropyl methylcellulose
(METHOCEL® F4M de DOW CHEMICAL) 0, 1 g Conservateur q.s.(METHOCEL ® F4M from DOW CHEMICAL) 0, 1 g Preservative qs
Eau déminéralisée q.s.p. 100 gDemineralized water q.s.p. 100g
*PEG : polyéthylèneglycol, OE : motifs d'oxyde d'éthylène* PEG: polyethylene glycol, OE: ethylene oxide units
On prépare la crème huile-dans-eau de la manière décrite dans l'exemple A. The oil-in-water cream is prepared as described in Example A.
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002218346A AU2002218346A1 (en) | 2000-11-17 | 2001-11-09 | Insoluble organic uv filters and cosmetic use thereof |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR00/14897 | 2000-11-17 | ||
| FR0014897A FR2816842B1 (en) | 2000-11-17 | 2000-11-17 | INSOLUBLE ORGANIC UV FILTERS AND THEIR USE IN COSMETICS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2002039972A1 true WO2002039972A1 (en) | 2002-05-23 |
Family
ID=8856621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/FR2001/003482 Ceased WO2002039972A1 (en) | 2000-11-17 | 2001-11-09 | Insoluble organic uv filters and cosmetic use thereof |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002218346A1 (en) |
| FR (1) | FR2816842B1 (en) |
| WO (1) | WO2002039972A1 (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2153815A1 (en) | 2008-08-05 | 2010-02-17 | Isdin S.A. | Use of urea containing compositions |
| EP2153814A1 (en) | 2008-08-05 | 2010-02-17 | Isdin S.A. | Use of compositions comprising urea |
| CN104072425A (en) * | 2014-07-09 | 2014-10-01 | 大连理工大学 | Benzimidazole compound and application thereof |
| WO2019180042A1 (en) | 2018-03-20 | 2019-09-26 | Dsm Ip Assets B.V. | Micronized 1,4-di(benzoxazol-2'-yl)benzene |
| WO2019180039A1 (en) | 2018-03-20 | 2019-09-26 | Dsm Ip Assets B.V. | Topical composition |
| WO2019180038A1 (en) | 2018-03-20 | 2019-09-26 | Dsm Ip Assets B.V. | Topical composition |
| WO2021047905A1 (en) | 2019-09-11 | 2021-03-18 | Dsm Ip Assets B.V. | Topical compositions |
| WO2021047904A1 (en) | 2019-09-11 | 2021-03-18 | Dsm Ip Assets B.V. | Microbiocidal use |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995022959A2 (en) * | 1994-02-23 | 1995-08-31 | Ciba-Geigy Ag | Sunscreen compositions |
| US5501850A (en) * | 1992-02-13 | 1996-03-26 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Use of benzimidazole derivatives as light protection filters |
| US5518713A (en) * | 1995-02-13 | 1996-05-21 | 3V Inc. | Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them |
| WO1997003643A1 (en) * | 1995-07-22 | 1997-02-06 | Ciba Specialty Chemicals Holding Inc. | Sunscreen compositions |
| EP0893119A1 (en) * | 1997-07-26 | 1999-01-27 | Ciba SC Holding AG | UV-protection formulation |
| EP0921126A1 (en) * | 1997-12-04 | 1999-06-09 | L'oreal | Silicon containing benz-x-azole compounds, cosmetic sunscreen agents containing them and their uses |
| US5962452A (en) * | 1997-05-16 | 1999-10-05 | Ciba Specialty Chemicals Corporation | Resorcinyl-triazines |
| US5961960A (en) * | 1996-11-20 | 1999-10-05 | Haarmann & Reimer Gmbh | Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation |
| WO1999066896A1 (en) * | 1998-06-22 | 1999-12-29 | Ciba Specialty Chemicals Holding Inc. | Sun screen formulations |
| WO2000078277A1 (en) * | 1999-06-18 | 2000-12-28 | Ciba Specialty Chemicals Holding Inc. | Micropigment mixture |
-
2000
- 2000-11-17 FR FR0014897A patent/FR2816842B1/en not_active Expired - Fee Related
-
2001
- 2001-11-09 WO PCT/FR2001/003482 patent/WO2002039972A1/en not_active Ceased
- 2001-11-09 AU AU2002218346A patent/AU2002218346A1/en not_active Abandoned
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5501850A (en) * | 1992-02-13 | 1996-03-26 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Use of benzimidazole derivatives as light protection filters |
| WO1995022959A2 (en) * | 1994-02-23 | 1995-08-31 | Ciba-Geigy Ag | Sunscreen compositions |
| US5518713A (en) * | 1995-02-13 | 1996-05-21 | 3V Inc. | Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them |
| WO1997003643A1 (en) * | 1995-07-22 | 1997-02-06 | Ciba Specialty Chemicals Holding Inc. | Sunscreen compositions |
| US5961960A (en) * | 1996-11-20 | 1999-10-05 | Haarmann & Reimer Gmbh | Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation |
| US5962452A (en) * | 1997-05-16 | 1999-10-05 | Ciba Specialty Chemicals Corporation | Resorcinyl-triazines |
| EP0893119A1 (en) * | 1997-07-26 | 1999-01-27 | Ciba SC Holding AG | UV-protection formulation |
| EP0921126A1 (en) * | 1997-12-04 | 1999-06-09 | L'oreal | Silicon containing benz-x-azole compounds, cosmetic sunscreen agents containing them and their uses |
| WO1999066896A1 (en) * | 1998-06-22 | 1999-12-29 | Ciba Specialty Chemicals Holding Inc. | Sun screen formulations |
| WO2000078277A1 (en) * | 1999-06-18 | 2000-12-28 | Ciba Specialty Chemicals Holding Inc. | Micropigment mixture |
Cited By (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2153815A1 (en) | 2008-08-05 | 2010-02-17 | Isdin S.A. | Use of urea containing compositions |
| EP2153814A1 (en) | 2008-08-05 | 2010-02-17 | Isdin S.A. | Use of compositions comprising urea |
| CN104072425A (en) * | 2014-07-09 | 2014-10-01 | 大连理工大学 | Benzimidazole compound and application thereof |
| CN104072425B (en) * | 2014-07-09 | 2016-12-07 | 大连理工大学 | Benzimidazole compounds and their applications |
| US11931444B2 (en) | 2018-03-20 | 2024-03-19 | Dsm Ip Assets B.V. | Topical composition |
| JP2021516679A (en) * | 2018-03-20 | 2021-07-08 | ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. | Topical composition |
| WO2019180038A1 (en) | 2018-03-20 | 2019-09-26 | Dsm Ip Assets B.V. | Topical composition |
| CN111867548A (en) * | 2018-03-20 | 2020-10-30 | 帝斯曼知识产权资产管理有限公司 | surface composition |
| CN111867553A (en) * | 2018-03-20 | 2020-10-30 | 帝斯曼知识产权资产管理有限公司 | surface composition |
| CN111902126A (en) * | 2018-03-20 | 2020-11-06 | 帝斯曼知识产权资产管理有限公司 | Micronized 1,4-bis(benzoxazol-2'-yl)benzene |
| KR20200134263A (en) * | 2018-03-20 | 2020-12-01 | 디에스엠 아이피 어셋츠 비.브이. | Topical composition |
| KR20200135415A (en) * | 2018-03-20 | 2020-12-02 | 디에스엠 아이피 어셋츠 비.브이. | Topical composition |
| KR20200135813A (en) * | 2018-03-20 | 2020-12-03 | 디에스엠 아이피 어셋츠 비.브이. | Finely divided 1,4-di(benzoxazol-2'-yl)benzene |
| WO2019180039A1 (en) | 2018-03-20 | 2019-09-26 | Dsm Ip Assets B.V. | Topical composition |
| KR102826149B1 (en) * | 2018-03-20 | 2025-06-27 | 디에스엠 아이피 어셋츠 비.브이. | Differentiated 1,4-di(benzoxazol-2'-yl)benzene |
| WO2019180042A1 (en) | 2018-03-20 | 2019-09-26 | Dsm Ip Assets B.V. | Micronized 1,4-di(benzoxazol-2'-yl)benzene |
| JP2021516678A (en) * | 2018-03-20 | 2021-07-08 | ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. | Micronized 1,4-di (benzoxazole-2'-yl) benzene |
| JP2021516677A (en) * | 2018-03-20 | 2021-07-08 | ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. | Topical composition |
| KR102790477B1 (en) * | 2018-03-20 | 2025-04-04 | 디에스엠 아이피 어셋츠 비.브이. | Topical compositions |
| KR102790480B1 (en) | 2018-03-20 | 2025-04-04 | 디에스엠 아이피 어셋츠 비.브이. | Topical compositions |
| JP7541923B2 (en) | 2018-03-20 | 2024-08-29 | ディーエスエム アイピー アセッツ ビー.ブイ. | Micronized 1,4-di(benzoxazol-2'-yl)benzene |
| CN111867553B (en) * | 2018-03-20 | 2024-06-07 | 帝斯曼知识产权资产管理有限公司 | Surface composition |
| US11992544B2 (en) | 2018-03-20 | 2024-05-28 | Dsm Ip Assets B.V. | Topical composition |
| JP7238225B2 (en) | 2018-03-20 | 2023-03-14 | ディーエスエム アイピー アセッツ ビー.ブイ. | topical composition |
| CN111867548B (en) * | 2018-03-20 | 2023-03-28 | 帝斯曼知识产权资产管理有限公司 | Surface composition |
| JP7413637B2 (en) | 2018-03-20 | 2024-01-16 | ディーエスエム アイピー アセッツ ビー.ブイ. | topical composition |
| US11958836B2 (en) | 2018-03-20 | 2024-04-16 | Dsm Ip Assets B.V. | Micronized 1,4-di(benzoxazol-2′-yl)benzene |
| WO2021047905A1 (en) | 2019-09-11 | 2021-03-18 | Dsm Ip Assets B.V. | Topical compositions |
| CN114401708B (en) * | 2019-09-11 | 2024-01-23 | 帝斯曼知识产权资产管理有限公司 | Topical compositions |
| JP2022547261A (en) * | 2019-09-11 | 2022-11-11 | ディーエスエム アイピー アセッツ ビー.ブイ. | Use of microbicides |
| JP7491516B2 (en) | 2019-09-11 | 2024-05-28 | ディーエスエム アイピー アセッツ ビー.ブイ. | Use of microbicides |
| JP2022546938A (en) * | 2019-09-11 | 2022-11-10 | ディーエスエム アイピー アセッツ ビー.ブイ. | topical composition |
| US20220346377A1 (en) * | 2019-09-11 | 2022-11-03 | Dsm Ip Assets B.V. | Novel compositions |
| JP7582751B2 (en) | 2019-09-11 | 2024-11-13 | ディーエスエム アイピー アセッツ ビー.ブイ. | Topical Compositions |
| CN114401708A (en) * | 2019-09-11 | 2022-04-26 | 帝斯曼知识产权资产管理有限公司 | Topical compositions |
| CN114364259A (en) * | 2019-09-11 | 2022-04-15 | 帝斯曼知识产权资产管理有限公司 | Bactericidal use |
| WO2021047904A1 (en) | 2019-09-11 | 2021-03-18 | Dsm Ip Assets B.V. | Microbiocidal use |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002218346A1 (en) | 2002-05-27 |
| FR2816842A1 (en) | 2002-05-24 |
| FR2816842B1 (en) | 2005-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0944624B1 (en) | Insoluble s-triazine derivatives and their use as uv filters | |
| EP2196189B1 (en) | Cosmetic sunscreen compositions based on synergistic filter mixture and their use | |
| FR2830773A1 (en) | USE OF AMPHIPHILIC COPOLYMERS TO STABILIZE DISPERSIONS OF INSOLUBLE ORGANIC COMPOUNDS FILTERING UV RADIATION, DISPERSIONS STABILIZED BY SUCH COPOLYMERS AND COSMETIC COMPOSITIONS CONTAINING THE SAME | |
| FR2720640A1 (en) | Photoprotective cosmetic compositions based on a synergistic mixture of filters and nanopigments and uses. | |
| FR2826365A1 (en) | PHOTOPROTECTIVE COSMETIC COMPOSITIONS CONTAINING AMIDE, SULFONAMIDE OR AROMATIC ACRYLONITRILE DERIVATIVES AND NOVEL AMIDE, SULFONAMIDE OR ACRYLONITRILE CARBAMATE DERIVATIVES | |
| WO2002049597A2 (en) | Cosmetic solar protection compositions based on a synergic mixture of filters and uses | |
| EP1064922B9 (en) | Photoprotective compositions containing a bis-hydroxyphenylbenzotriazole compound and a compound having benzoazolyl or benzodiazolyl groups | |
| EP1471059B1 (en) | 2,4,6-tris(dineopentyl 4'-aminobenzalmalonate)-s-triazin, sunscreen compositions containing this compound and its use | |
| WO2002039972A1 (en) | Insoluble organic uv filters and cosmetic use thereof | |
| WO2001049686A1 (en) | S-triazine derivatives and their use as uv filters | |
| FR3073408B1 (en) | COMPOSITIONS COMPRISING AT LEAST ONE ACRYLIC POLYMER AND AT LEAST ONE INSOLUBLE ORGANIC FILTER | |
| EP1430881B1 (en) | Compositions comprising a triazine derivative solubilized in a eutectic mixture of n-butylphthalimide/isopropylphthalimide and cosmetic use | |
| FR2842419A1 (en) | METHOD FOR ENLARGING THE UV ABSORPTION SPECTRUM OF A UV-A SOLAR FILTER AND MATERIAL OBTAINED BY A SOL-GEL ROUTE CONTAINING SAID FILTER | |
| EP1568700B1 (en) | S-triazine derivatives containing at least two silated p-aminobenzalmalonate groups, sunscreen compositions containing these derivatives as well as the use of the derivatives | |
| FR2801207A1 (en) | Cosmetic composition contains mono- and poly-carboxylic naphthalene acid derivative(s) and 1,4-di(3-methylidene-10-camphosulfonic acid)benzene as part of a UV filter system | |
| EP1281391B1 (en) | Organic insoluble UV filters of the aryl vinylene ketone type and their use in cosmetics | |
| FR2801206A1 (en) | Cosmetic composition contains mono- and poly-carboxylic naphthalene acid derivative(s) and a photoprotective containing a hydroxyphenylbenzotriazole UV filter system | |
| FR2795319A1 (en) | Photostabilization of and 4-(tert. butyl)-4'-methoxy-dibenzylmethane against UV radiation comprises associating it with a ferulic acid derivative(s) | |
| FR2801213A1 (en) | Cosmetic composition contains a naphthalenic compound and a photoprotective containing a hydroxyphenylbenzotriazole UV filter system | |
| EP1466908A1 (en) | S-tiazin-derivatives having at least one grafted para-aminobenzalmalonic acid salt and sun screening preparations comprising those derivatives | |
| FR2867188A1 (en) | S-TRIAZINE DERIVATIVES HAVING PARA-ALKOXYPHENYL GROUP AND AT LEAST ONE GRAINED AMINOBENZALMALONIC GROUP; COSMETIC COMPOSITIONS CONTAINING THESE DERIVATIVES; USES OF SAID S-TRI DERIVATIVES | |
| EP1278718B1 (en) | Novel amino acid derivatives, preparation method, compositions containing same and uses thereof as sunscreens | |
| FR2842418A1 (en) | PHOTOSTABILIZED MATERIAL CONTAINING SOLAR-GEL-PRODUCED DIBENZOYLMETHANE SOLAR FILTER AND COSMETIC AND / OR DERMOTOLOGICAL COMPOSITION CONTAINING SUCH MATERIAL | |
| EP1454896A1 (en) | Amine, amide, sulfonamide and carbamate derivatives of benzylidenemalonoc acid salts photoprotective cosmetic compositions containing them | |
| EP1424063A1 (en) | Cosmetic sunscreen compositions comprising 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one derivatives and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |